Raise Awareness

Nuestros 10 videos más populares acerca del Parkinson en español

Older hispanic man watching a video on tablet

Tanto si está recién diagnosticado con la enfermedad de Parkinson (EP) como si lleva años viviendo con ella, ¡a veces un breve video es todo lo que necesita para aprender algo nuevo! 

Eche un vistazo a nuestros 10 videos más populares en español y vea cómo pueden empoderarlo para manejar sus síntomas con confianza.  

Desde ejercicios de voz hasta entender las causas de la EP, estos videos en español ofrecen valiosos conocimientos, consejos de expertos y sugerencias prácticas.  

1. Ejercicio de voz para la enfermedad de Parkinson 

Así como la EP afecta el movimiento en otras partes del cuerpo, también afecta los músculos de la cara, la boca y la garganta que se utilizan para hablar y tragar. Acompañe a la Parkinson’s Foundation y a la terapeuta del habla y el lenguaje Leslie J. Ledée Lozada en esta serie de ejercicios para la voz. 

2. Los ejercicios recomendados para el Parkinson 

No importa en qué punto de la enfermedad de Parkinson se encuentre, el movimiento es medicina. Las investigaciones demuestran que el ejercicio y la actividad física no sólo pueden mantener y mejorar la movilidad, la flexibilidad y el equilibrio, sino también aliviar los síntomas no motores de la EP. Vea este video para aprender por qué debería hacer ejercicio y cómo puede mejorar su calidad de vida. 

3. ¿Cuáles son las causas de la enfermedad de Parkinson?  

Aunque cada persona experimenta el Parkinson de manera distinta, existen algunos puntos en común. Vea este video para saber cómo están relacionados los factores genéticos y ambientales con la EP.  

4. ¿Cuáles son las etapas de la enfermedad de Parkinson?  

Aunque los síntomas y la progresión de la enfermedad son únicos para cada persona, conocer los estadios típicos del Parkinson puede ayudarle a anticipar y manejar mejor los cambios a medida que ocurren.  

5. Viernes de Ejercicio - Danza: explorando ritmos desde la silla 

En este video de Viernes de Ejercicio nos enfocamos en la coordinación y la percepción del espacio, todo desde la comodidad de una silla. 

6. Controlando los síntomas de la enfermedad de Parkinson 

Hay mucho que saber acerca del Parkinson y el manejo de los síntomas. En este video, aprenda cómo se trata y, lo más importante aún, cómo vivir mejor con la EP. 

7. Lunes de Atención Plena - Relájese y respire 

Descubra cómo la atención plena (mindfulness) y la respiración consciente pueden ayudar a reducir el estrés y mejorar su bienestar. En esta sesión de Lunes de Atención Plena aprenderá técnicas sencillas para relajarse, centrarse en el presente y cultivar un mayor equilibrio emocional en su vida diaria. 

8. Cambios de comportamiento y la enfermedad de Parkinson   

Explore la progresión de la enfermedad de Parkinson y su impacto en el estado de ánimo, la personalidad y el comportamiento en este video de Miércoles de Bienestar. 

9. Explorando terapias complementarias para el Parkinson 

Adéntrese en el mundo de las terapias complementarias y su papel en mejorar la calidad de vida de las personas con la EP. 

10. La nutrición y el Parkinson: Aprender a comer y cuidar de su alimentación  

El Dr. Ramón de Cangas, dietista y nutricionista, comparte consejos para ayudar a las personas con Parkinson a seguir una dieta saludable

Ver más videos en nuestro Canal de YouTube: Canal en Español: Recursos para ti.  

Educational Events

PD GENEration: Advancing Research, Empowering Lives

Virtual ( Zoom )
1:00 pm to 2:00 pm EST
FREE
Husband and wife lookin at a tablet while on their porch

PDGENEration: Mapping the Future of Parkinson's Disease is transforming the landscape of Parkinson's research while empowering individuals with knowledge. This webinar will cover an overview of the PD GENEration study, including its mission and the exciting progress made so far. We will also provide a discussion of the future of PD GENEration and insights from a participant panel, featuring their personal stories and the impactful actions they have taken based on their genetic results.

Speakers

James Beck, PhD
Chief Scientific Officer, Parkinson's Foundation

Jennifer L. Verbrugge, MS, CGC
Licensed, Certified Genetic Counselor
Indiana University School of Medicine
Department of Medical and Molecular Genetics
Hereditary Genomics Division

 

There is no charge to attend, but registration is required. This program is open to people with Parkinson's, their family, friends, and the community.

We want to thank this webinar's sponsor, Prevail Therapeutics, for supporting our mission.

Prevail Therapeutics logo

PD Health @ Home is presented by the Light of Day Foundation, whose generosity has made this programming possible.

Light of Day

This is a virtual program, taking place live, using the online Zoom platform. Instructions on joining the webinar are provided after registering.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Educational Events

Managing Changing Symptoms

10:00 am to 12:30 pm CDT
FREE
Managing Changing Symptoms Banner Updated

Check-in and Resource Fair start at 9 a.m.
The program will be held from 10a.m. - 12:30 p.m.

After many years of good symptom management, Parkinson’s disease may become more challenging.  Learn how Parkinson’s symptoms may change over time and new strategies available for managing them.

This program is free. Lunch will be served.


Expert Speakers

Karuna Dewan, MD, FACS
LSU Health Shreveport, Ark-LA-Tex Center for Voice, Airway and Swallowing

Sarah Quintana, MS, L-SLP, CCC-SLP
LSU Health Shreveport, Ark-LA-Tex Center for Voice, Airway and Swallowing

Wendy Taylor, AGPC-CNP
WK Pierremont Neurology Clinic

Jamie Toms, MD
LSU Health Shreveport, Department of Neurosurgery


Stretch Break Provided by:

Julie Schwertfeger, PhD, DPT, MBA, CBIST
Board-Certified Clinical Specialist in Neurologic Physical Therapy, LSU Health Shreveport

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Advancing Research

Actualización: Un nuevo estudio revela que fármacos como el Ozempic son ineficaces en el tratamiento del Parkinson

ozempic pen injection

Este mes de febrero, un nuevo estudio publicado en la revista médica The Lancet ha despertado importantes dudas acerca de la eficacia potencial de la clase de fármacos para la diabetes agonistas del receptor GLP-1 en el tratamiento de la enfermedad de Parkinson (EP).  

Un ensayo clínico de fase 3 evaluó el agonista del receptor de GLP-1 llamado Exenatida. El estudio, que constó de 194 participantes a quienes se dio seguimiento durante dos años, encontró que el uso diario de Exenatide no proporcionó ninguna mejora significativa para los síntomas del Parkinson en comparación con el placebo. Esta falta de mejora fue consistente en todos los grupos de edad, sexos y estadios de la EP. Los investigadores también realizaron tomografías computarizadas (CT scan) del cerebro antes y después del estudio en participantes seleccionados y descubrieron que la Exenatida no afectaba la actividad dopaminérgica en las regiones cerebrales relevantes para la EP. 

Estos resultados sugieren que los actuales medicamentos agonistas del receptor GLP-1 no son eficaces como tratamientos modificadores de la enfermedad de Parkinson. A medida que los científicos aprendan más acerca de la vía biológica del GLP-1 y cómo afecta la salud de las neuronas dopaminérgicas, es probable que en el futuro se desarrollen y se pongan a prueba nuevos medicamentos con GLP-1 específicamente diseñados para el Parkinson. 

¿Podrían los medicamentos para la diabetes como el Ozempic ser un tratamiento para el Parkinson? 

Un ensayo clínico de lixisenatida, un fármaco aprobado por la FDA en 2016 para tratar la diabetes, mostró potencial para reducir los síntomas motores en personas con Parkinson 

La enfermedad de Parkinson (EP) es un trastorno neurodegenerativo en el que las células cerebrales productoras de dopamina se descomponen lentamente con el paso del tiempo. Esta pérdida de dopamina provoca diversos síntomas motores, como temblor, rigidez, lentitud de movimientos y problemas con el equilibrio. Aunque los tratamientos actuales pueden ayudar a controlar muchos de los síntomas de la EP, no abordan las causas de la enfermedad y, por lo tanto, no pueden evitar su progresión.  

Nuevas investigaciones sugieren una posible relación entre la disminución de la sensibilidad del cerebro a la hormona insulina y la progresión del Parkinson. Esta observación ha llevado a los investigadores a estudiar si los medicamentos antidiabéticos que ayudan a controlar los niveles de insulina podrían ralentizar la progresión del Parkinson. 

Los fármacos Ozempic y Wegovy pertenecen a una clase de medicamentos para la diabetes llamados agonistas de los receptores GLP-1 que, junto con algunos otros medicamentos para la diabetes, han mostrado potencial para reducir el riesgo de desarrollar Parkinson en personas con diabetes. Estos fármacos imitan la acción de una hormona natural que regula los niveles de azúcar en sangre. 

Sin embargo, se desconoce si los fármacos agonistas del receptor GLP-1 pueden beneficiar a las personas con Parkinson que no tienen diabetes. 

Un reciente ensayo clínico, publicado en el New England Journal of Medicine, analizó si un agonista del GLP-1 llamado lixisenatida podría ofrecer un nuevo enfoque de tratamiento para las personas en los primeros estadios del Parkinson. El estudio mostró que la lixisenatida, que fue aprobada por la FDA en 2016 para ayudar a los diabéticos a controlar el azúcar en la sangre, ayudó con los síntomas motores en personas con la EP y podría ralentizar la progresión del Parkinson.  

Como parte de este estudio, un modelo de ratón del Parkinson demostró que la lixisenatida mejoraba los problemas motores y preservaba las células cerebrales, lo que sugiere que los agonistas del GLP-1 podrían tratar las causas subyacentes de la EP.  

Además, la lixisenatida no es el único agonista del receptor GLP-1 con potenciales aplicaciones terapéuticas para el Parkinson: al menos otros seis medicamentos similares están bajo evaluación actualmente como tratamiento potencial para la EP. Sin embargo, en comparación con la liraglutida y la semaglutida (como Wegovy), la lixisenatida parece ser más eficaz en atravesar la barrera hematoencefálica. 

Resultados del estudio 

El nuevo estudio, —un ensayo clínico de fase 2—, reclutó a 156 personas con Parkinson, que fueron asignadas aleatoriamente para recibir lixisenatida o un placebo. Los participantes fueron diagnosticados con Parkinson dentro de los tres años anteriores y estaban tomando medicamentos dopaminérgicos, como la levodopa y continuaron haciéndolo durante el ensayo. Para cada participante, los investigadores evaluaron los síntomas antes del tratamiento con la inyección diaria de placebo o lixisenatida y 12 meses después. 

Tras 12 meses de tratamiento, las personas que recibieron lixisenatida mostraron mejores resultados en sus síntomas motores en comparación con las que recibieron un placebo. Mientras que los síntomas motores del grupo de lixisenatida no cambiaron en comparación con el inicio del ensayo, el grupo de placebo experimentó un empeoramiento de sus síntomas.  

Tras 12 meses de tomar lixisenatida o un placebo, los participantes se sometieron a dos meses sin ningún tratamiento y se volvieron a evaluar los síntomas. El grupo de lixisenatida mostró mejores síntomas motores en comparación con el grupo de control después de dos meses, lo que sugiere que la lixisenatida puede tener un impacto positivo en la progresión de la enfermedad.  

Cabe destacar que los que recibieron lixisenatida tuvieron más efectos secundarios gastrointestinales: un 46% de los participantes que tomaron lixisenatida tuvieron náuseas y 13% experimentaron vómitos. Aproximadamente un tercio de los participantes (28 personas) que recibieron lixisenatida optaron por una dosis inferior durante el estudio debido a los efectos secundarios. 

Destacados 

  • En el estudio participaron 156 personas con Parkinson, que fueron asignadas aleatoriamente a recibir una inyección diaria de lixisenatida (un agonista del GLP-1) o un placebo. 

  • Tras un año de tratamiento, las personas que recibieron lixisenatida mostraron mejores resultados en sus síntomas motores en comparación con las que recibieron un placebo. 

  • La lixisenatida provocó efectos secundarios gastrointestinales en muchos participantes: un 46% tuvo náuseas y un 13% experimentó vómitos. 

¿Qué significa esto para los medicamentos del GLP-1 y el Parkinson? 

Este estudio puede indicar que ciertos agonistas del GLP-1 podrían ser beneficiosos para reducir ciertos síntomas del Parkinson. Estos prometedores resultados inspirarán más investigaciones sobre los efectos a largo plazo de la lixisenatida en la progresión de la EP.  

Este estudio tenía un tamaño de muestra pequeño y sólo evaluó el fármaco en los recién diagnosticados (diagnosticados en los últimos tres años). Se necesitan estudios más amplios, con un número significativamente mayor de participantes que vivan con rangos más amplios de los estadios de la EP, antes de que podamos establecer una conexión entre los agonistas del GLP-1 y el control de los síntomas o la progresión de la enfermedad.  

Por último, actualmente se están investigando muchos agonistas del GLP-1 para el tratamiento de la EP y otros fármacos similares han mostrado resultados menos prometedores en comparación con la lixisenatida. Se necesitan más investigaciones para comprender las diferencias entre los distintos agonistas del GLP-1 sobre los síntomas de la EP.  

¿Qué significan estos hallazgos para las personas con la EP en este momento? 

Actualmente, los agonistas del GLP-1 sólo están aprobados para el tratamiento de la diabetes y la obesidad. Las personas con Parkinson que también tienen diabetes y obesidad deben hablar con su médico antes de empezar a tomar un agonista del GLP-1. Actualmente no hay pruebas suficientes que respalden el uso de agonistas del GLP-1 como la lixisenatida como tratamiento para las personas con Parkinson que no tienen diabetes ni obesidad.  

Además, la pérdida de peso asociada a los agonistas del GLP-1 puede ser un problema para las muchas personas con Parkinson que experimentan una pérdida de peso involuntaria a lo largo de la enfermedad.  

Cabe destacar que la lixisenatida ya no está disponible en los EE.UU.  

Aprenda más 

La Parkinson’s Foundation cree en el empoderamiento de la comunidad de Parkinson a través de la educación. Aprenda más acerca de la EP y de los temas en este artículo a través de nuestros recursos mencionados abajo o llame a nuestra Línea de Ayuda gratuita al 1-800-4PD-INFO (1-800-473-4636), opción 3 para español, para obtener respuestas a sus preguntas acerca del Parkinson. 

Raise Awareness

From Fear to Care: How to Address Parkinson’s Hospital Risks

Female doctor talking to hospital patient in bed

For most people, being in the hospital can be stressful experience. However, people with Parkinson’s disease (PD) are at a higher risk of hospitalization and face many challenges while in the hospital. This year alone, four of every 12 people with PD will be hospitalized. It is important for all people with Parkinson’s to be aware of the risks, prepare ahead of time and know how to advocate for their needs while in the hospital.

When admitted into the hospital, people with PD may experience worsening or new symptoms. Confusion or thinking changes can develop because of stress, infection, fatigue, sleep disturbances, surgery or new medications. Fortunately, the Parkinson’s Foundation is here to help.

To raise awareness of common hospital challenges, we highlight three hospital experiences from people with Parkinson’s below. The Parkinson’s Foundation is committed to helping people like Cindy, Ron and Julie, receive better hospital care. We’re thankful for their willingness to share their share to help educate and empower our community.

Cindy’s Story

Cindy prepared for a routine surgery. An avoidable medication interaction still caused hallucinations. 

I recently had a total knee replacement. Beforehand I did everything I was told that was needed to prepare. I had gone to my primary doctor and my neurologist to get clearance and felt calm going into surgery.  

My neurologist wrote notes on what medications I should not take. But when I went to the hospital for my surgery, the nurse doing my intake didn’t know I had Parkinson’s disease (PD). Not one person I spoke to had looked at the notes my doctor sent. I was left feeling fearful and alone.  

I went in thinking maybe there would be some glitch during my hospitalization, but it wasn’t just one thing. I didn’t get my Parkinson’s medications when I woke up from surgery, they didn’t have my medications available that night and they gave me a medication that I should have never been given, which led to a major reaction. 

After being discharged, at home I took the pain medication prescribed at the hospital and became delirious. I was hallucinating and had a 103-degree fever. My husband and I didn’t know what was wrong. I found out later that I had a medication interaction caused by Serotonin Syndrome, which is rare but can be fatal. This was a worst-case scenario for me and set my recovery back.  

I was shocked that this happened even after everything I did to prepare for my surgery. I am a PD advocate, and I am very involved in the Parkinson’s community. I heard bad hospitalization stories before, but you just don't realize how bad things can be until they happen to you.  

I’m happy to share that since this happened, I spoke to the patient liaison about my experience, and have since joined their patient advocacy council. Through participating I will be able to help the hospital address the problems I experienced and help ensure that others will not go through what I went through.  

Cindy shares her story in this video:


Julie’s Story

An unexpected reaction to THC sent Julie to the emergency department in an unknown city. When she arrived, the team didn’t believe she had Parkinson’s.

Julie Obreiter selfie

Julie was on a cross-country road trip with her daughter when she began experiencing severe dyskinesia and cramping. This was a fairly common experience for her, and sometimes, she used THC (a form of medical marijuana) to find relief. However, when she did this time, she became unresponsive, and her daughter had to pull over to call 9-1-1.  

When they arrived at the hospital, the emergency room (ER) team didn’t believe her when she said that she had Parkinson’s disease. They refused to perform any tests or allow her to take her Parkinson’s medications. Unfortunately, it took several hours to convince the medical team that Parkinson’s medications were essential.  

Once they realized that her Parkinson’s medications were not street drugs, she was finally allowed to take them get her symptoms under control.  

Read Julie’s Full Story Now


Ron and Amy’s Story

Ron and Amy prepared for an emergency room visit. But when Covid-19 sent Ron to the hospital it still took too long for him to receive his Parkinson’s medications. 

Ron McConnell in hospital bed holding a sign with Amy McConnell next to him

Ron and Amy experienced an unthinkable hospital stay in 2023 after Ron, diagnosed with Parkinson’s in 2019, developed a severe case of Covid-19.  

Prior to the emergency visit, they prepared for the unexpected with resources from the Parkinson’s Foundation Hospital Safety Guide. They asked for these materials to be scanned into his electronic chart, knowing that it was essential that the medical team understood Ron’s diagnosis and the importance of administering his Parkinson’s medications in a timely manner.  

Despite being assured that Ron’s chart had been updated, they later learned that this had not been the case — the medical team was unaware of his Parkinson’s diagnosis. 

Despite Amy’s pleading, Ron did not receive any of his Parkinson’s medications on time. After going into respiratory failure, a life-or-death situation, a new doctor took over, and made time to listen to Amy. He agreed to administer Parkinson’s medications and took great care of Ron for several days throughout the recovery period. In the end, Ron recovered and the new doctor declared that by advocating for Ron’s Parkinson’s needs, Amy had made him an even better doctor.  

Read Ron and Amy’s Full Story Now

Hospital Safety Tools Designed to Help  

Prepare for your next planned or unplanned hospital stay with the below resources designed to help you.  

  1. Share the Parkinson’s Care Summary for Health Professionals with attending hospital staff (from nurses to doctors) to alert them of medications to avoid and safe alternatives.    

  1. Keep the Medical Alert Card in your wallet so that you have it in case you need to show that you have Parkinson’s.  

  1. Bring your Doctor’s Letter: Parkinson’s Hospital Care Needs, signed by your primary Parkinson’s care provider, to emphasize the importance of getting your Parkinson’s medications.  

  2. Document details following a difficult hospital stay with the Processing a Challenging Hospital Experience online form. Use it to reflect and record what did not go well and what you want others to understand.

Most of these tools and more can be found in the Parkinson’s Foundation Hospital Safety Guide, designed to help you prepare for and navigate a hospital stay. 

Order or download a free copy of the Hospital Safety Guide now.

Fundraising Events

2026 El Tour de Tucson

6:00 am to 6:00 pm MST
Participant in Tucson Race

The Parkinson's Foundation is an official charity partner for the 2026 Tour de Tucson. By signing up to ride as a Parkinson's Champion you commit to raising funds and awareness for the Parkinson's Foundation. 

Fundraising Commitments:

  • Honorary Rider (register with Tour de Tucson first): $500

The HonorHealth Tour de Tucson offers challenging and scenic courses that will undoubtedly push the limits of cyclists. The Tour de Tucson has grown from just a few hundred participants in its early years to attracting thousands of riders from all over the world today!

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Fundraising Events

2026 Tour de Scottsdale

6:00 am to 6:00 pm CDT
Participant in Tucson Race

The Parkinson's Foundation is an official charity partner for the 2026 Tour de Scottsdale. By signing up to ride as a Parkinson's Champion you commit to raising funds and awareness for the Parkinson's Foundation. For the Tour de Scottsdale you have 2 registration options. Register at the $1,500 level and we will provide you with an entry to the race or purchase your own entry and join us as an honorary champion at the $500 level.

Fundraising Commitments:

  • VIP Entry (bib from the Parkinson's Foundation): $1,500
  • Honorary Rider (buy your own bib): $500
    • Register directly on the Tour de Scottsdale site

The HonorHealth Tour de Scottsdale offers challenging and scenic courses that will undoubtedly push the limits of cyclists. The Tour de Scottsdale has grown from just a few hundred participants in its early years to attracting thousands of riders from all over the world today! This incredible growth reflects not only the beauty of the route but the strength of the cycling community that comes together each year. The Metric Century Ride circumnavigates the McDowell Mountains riding through Scottsdale, Rio Verde and Fountain Hills. The Half Century is a scenic routes through Scottsdale, AZ that circles Pinnacle Peak.

Are you looking for a fun way to volunteer for the Parkinson's Foundation & raise your voice while raising awareness? Come out and cheer on our incredible athletes! Learn more and apply at Parkinson.org/ChampionsCheer.

If you have questions, send us an email. For more information about the race itself, visit the Tour de Scottsdale Homepage.
 

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Fundraising Events

2026 Grandma's Marathon Weekend

6:00 am to 6:00 pm CDT
Racers at Grandma's marathon

The Parkinson's Foundation is an official charity partner for the 2026 Grandma's Marathon Weekend. By signing up to run as a Parkinson's Champion you commit to raising funds and awareness for the Parkinson's Foundation, and in return you get access to a free entry (bib) to the race in addition to tons of other fun benefits and perks. You can reserve your bib now by creating a fundraising page at PDChampionsGrandmas.org.

Fundraising Commitments:

  • Marathon - $1,000
  • Half Marathon - $750

Since the inaugural race in 1977, Grandma’s Marathon has grown into something much bigger than just a 26.2-mile race along the scenic north shore of Minnesota. It’s now become a “can’t-miss” weekend in June, a moment when participants of all calibers come together to celebrate the vigor of the human spirit. It’s a day the word “impossible” ceases to exist, a day that you and thousands of others will start as strangers but finish as friends. So get ready to once again tie up your laces for another year of memories, miles, and human might.

Are you looking for a fun way to volunteer for the Parkinson's Foundation & raise your voice while raising awareness? Come out and cheer on our incredible athletes! Learn more and apply at Parkinson.org/ChampionsCheer.

If you have questions, send us an email at cposner@parkinson.org. For more information about the race itself, visit the Grandma's Marathon Homepage.

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Fundraising Events

2026 Denver Colfax Marathon Weekend

6:00 am to 6:00 pm MST
DenverEventPage

The Parkinson's Foundation is an official charity partner for the 2026 Denver Colfax Marathon Weekend. 

Thank you for making the incredible choice to become a Parkinson’s Champion Athlete and supporting our Parkinson’s community! Every mile run and dollar raised goes directly towards improving care and advancing research toward a cure.

Registration Process:

  • For this race athletes will FIRST purchase their own bib/entry from RunColfax.org, Choose either the Marathon, Half Marathon, Urban 10-Miler, Relay, or 5k
  • Then head to PDChampionsDenverColfax.org to register a fundraising page
  • There is no minimum fundraising requirement for the Colfax event this year, but we hope you will commit to raising at least $500
  • If you raise at least $150, you can earn your Parkinson's Champions Singlet to wear at the race!

The Denver Colfax Marathon is the premier marathon weekend in the Mountain West Region, committed to community, philanthropy, and fun. This year is the 20th anniversary of the race, so extra special! Originally created by the cities of Denver, Lakewood, and Aurora to recognize Colfax Avenue, the longest main street in America; it’s Denver’s only marathon.  The race has grown to be a nationally recognized event featuring unique courses incorporating the iconic landmarks of the Mile-High City.  In addition to Marathon Weekend, there are other events in the year such as the annual Colorado Running Hall of Fame evening with new inductees and high school athlete recognition.

Parkinson’s Champions are racing toward a cure! Our Parkinson’s Champions athletes raise funds and awareness for the Parkinson’s Foundation while competing in some of the world’s most popular endurance events. Every step we take brings us closer to a future without Parkinson’s disease, because Parkinson’s isn’t a sprint, it’s a marathon. Learn more at ParkinsonsChampions.org.

If you have questions, send us an email at KCourington@Parkinson.org. For more information about the race itself, visit the Denver Colfax Homepage.
 

Upcoming Events

Educational Events

Mindfulness Mondays - Mental Wellbeing

Each month, Dr. Rush invites you to slow down, breathe, and reconnect with yourself and your Parkinson’s community through a guided mindfulness practice. Together, we’ll explore simple ways to ground the body, calm the mind, and cultivate compassion and clarity that you can carry into your week.

Virtual
Videos & Webinars

Mental Wellness & Connection for Veterans with Parkinson's

Breaking the Silence: Mental Wellness & Connection for Veterans with Parkinson's

February 27, 2025

This program will bring awareness to the symptoms that are often unspoken among veterans with Parkinson’s. We will address the real impact of loneliness and isolation, offer strategies for managing post-traumatic stress disorder, and provide guidance on overcoming fears associated with symptoms. Explore resources and support options designed to relieve isolation and nurture meaningful connections.

Download Slides

Additional Resources

Presenter

Ellen Bradley, MD 
Assistant Professor, Department of Psychiatry and Behavioral Sciences 
Weill Institute for Neurosciences  

Back to Top